Literature DB >> 10985208

Multivariate continuation ratio models: connections and caveats.

P J Heagerty1, S L Zeger.   

Abstract

We develop semiparametric estimation methods for a pair of regressions that characterize the first and second moments of clustered discrete survival times. In the first regression, we represent discrete survival times through univariate continuation indicators whose expectations are modeled using a generalized linear model. In the second regression, we model the marginal pairwise association of survival times using the Clayton-Oakes cross-product ratio (Clayton, 1978, Biometrika 65, 141-151; Oakes, 1989, Journal of the American Statistical Association 84, 487-493). These models have recently been proposed by Shih (1998, Biometrics 54, 1115-1128). We relate the discrete survival models to multivariate multinomial models presented in Heagerty and Zeger (1996, Journal of the American Statistical Society 91, 1024-1036) and derive a paired estimating equations procedure that is computationally feasible for moderate and large clusters. We extend the work of Guo and Lin (1994, Biometrics 50, 632-639) and Shih (1998) to allow covariance weighted estimating equations and investigate the impact of weighting in terms of asymptotic relative efficiency. We demonstrate that the multinomial structure must be acknowledged when adopting weighted estimating equations and show that a naive use of GEE methods can lead to inconsistent parameter estimates. Finally, we illustrate the proposed methodology by analyzing psychological testing data previously summarized by TenHave and Uttal (1994, Applied Statistics 43, 371-384) and Guo and Lin (1994).

Mesh:

Year:  2000        PMID: 10985208     DOI: 10.1111/j.0006-341x.2000.00719.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  8 in total

1.  The differential impact of risk factors on illicit drug involvement in females.

Authors:  Arpana Agrawal; Charles O Gardner; Carol A Prescott; Kenneth S Kendler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-06       Impact factor: 4.328

2.  Concordance between personality disorder assessment methods.

Authors:  G Nestadt; C Di; J F Samuels; Y-J Cheng; O J Bienvenu; I M Reti; P Costa; W W Eaton; K Bandeen-Roche
Journal:  Psychol Med       Date:  2011-08-24       Impact factor: 7.723

3.  Screening mammograms by community radiologists: variability in false-positive rates.

Authors:  Joann G Elmore; Diana L Miglioretti; Lisa M Reisch; Mary B Barton; William Kreuter; Cindy L Christiansen; Suzanne W Fletcher
Journal:  J Natl Cancer Inst       Date:  2002-09-18       Impact factor: 13.506

4.  The stability of DSM personality disorders over twelve to eighteen years.

Authors:  Gerald Nestadt; Chongzhi Di; J F Samuels; O J Bienvenu; I M Reti; P Costa; William W Eaton; Karen Bandeen-Roche
Journal:  J Psychiatr Res       Date:  2009-08-04       Impact factor: 4.791

5.  Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.

Authors:  Joo Hyun O; Brandon S Luber; Jeffrey P Leal; Hao Wang; Vanessa Bolejack; Scott M Schuetze; Lawrence H Schwartz; Lee J Helman; Denise Reinke; Laurence H Baker; Richard L Wahl
Journal:  J Nucl Med       Date:  2016-01-21       Impact factor: 10.057

6.  Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer.

Authors:  Rachel C Jankowitz; Kristine Cooper; Mark G Erlander; Xiao-Jun Ma; Nicole C Kesty; Hongying Li; Mamatha Chivukula; Adam Brufsky
Journal:  Breast Cancer Res       Date:  2011-10-14       Impact factor: 6.466

7.  Gene Signature Associated With Bromodomain Genes Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma.

Authors:  Junwan Lu; Changrui Qian; Yongan Ji; Qiyu Bao; Bin Lu
Journal:  Front Genet       Date:  2021-06-02       Impact factor: 4.599

8.  Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.

Authors:  Anne S Quante; Alice S Whittemore; Tom Shriver; John L Hopper; Konstantin Strauch; Mary Beth Terry
Journal:  J Natl Cancer Inst       Date:  2015-05-08       Impact factor: 13.506

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.